Open AccessA Multicenter Study to Evaluate Subject Satisfaction With Two Treatments of AbobotulinumtoxinA a Year in the Glabellar Lines
Author(s) -
Joel Schlessinger,
Joel L. Cohen,
Ava Shamban,
Carolyn I. Jacob,
Kian Karimi,
Corey S. Maas,
V. M. Lane,
Sarah Coquis-Knezek,
Matthew H. Meckfessel
Publication year - 2020
Publication title -
dermatologic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.659
H-Index - 125
eISSN - 1524-4725
pISSN - 1076-0512
DOI - 10.1097/dss.0000000000002846
Subject(s) - medicine , patient satisfaction , psychosocial , clinical endpoint , confidence interval , multicenter study , quality of life (healthcare) , physical therapy , surgery , randomized controlled trial , psychiatry , nursing
Real-world re-treatment intervals for botulinum toxins vary, but most subjects receive treatment less frequently than the manufacturer-recommended minimum intervals. In subjects receiving treatment with AbobotulinumtoxinA (ABO) less frequently, high levels of satisfaction and psychosocial improvements in well-being, self-confidence, and quality of life are observed.